The fellow eye sub-study was designed to evaluate the safety and efficacy of a single dose (1.3x1011 GC/eye) of ABBV-RGX-314 using subretinal delivery in the fellow eye of previously treated patients.

DIAMOND program committees expanded with globally renowned retina experts ...

Vabysmo has received approval in more than 100 countries for DME and wet age-related macular degeneration, as well as in over ...

Early screening can prevent vision loss in diabetic patients, says ABHI SINGHAL There are over 101 million people affected ...

An explanation of how an NYU Langone Health surgical team performed the world's first combined face and whole-eye transplantation will be presented at the American College of Surgeons (ACS) Clinical ...

Research published in Scientific Reports reveals that long-term consumption of dark chocolate is beneficial in preventing ...

The investigators conducted a study in which they evaluated the retinal structure in patients with ametropic amblyopia and ...

Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today positive topline one-year results from ...

The ELEVATUM study showed clinically meaningful improvement in vision and reduction in retinal fluid in people with <a target= ...

A historic face and whole-eye transplant was made possible by innovative surgical methods ensuring optimal eye blood flow.

Researchers develop a revolutionary eye scanner that can detect early signs of diabetes, heart disease, and Alzheimer's.